“The fact that a single gene can restore normal cell function and reverse aging-related effects is incredible,” said Jason Gertz, who serves as a professor in the Department of Oncological Sciences at the University of Utah and shares leadership of the Genomics, Epigenetics, and Metabolism Program at Huntsman Cancer Institute.
His reaction, published online on Oct. 9 in the journal Aging Cell, follows the first functional characterization of a protein called BLST, which University of Utah researchers say may protect spinal discs from age-related damage.
The study, led by Robby D. Bowles, an associate professor of biomedical engineering, identified the gene ZNF865 — known as BLST — as a regulator of DNA damage and cellular aging in the cushionlike structures between the vertebrae.
Using the gene-editing tool CRISPR, the team raised and lowered BLST levels in human disc cells and in mouse and rat models. When researchers restored BLST production in human disc cells, signs of cellular aging and DNA damage fell. When they reduced BLST activity in rodents, the discs degenerated and the animals showed pain-related behaviors.
The stakes are considerable. Back pain ranks as the number three leading cause of disability as measured by disability-adjusted life years, behind only cardiac disease and drug use disorders, according to the study team. Discs act as the cushionlike structures between vertebrae that allow the spine to move, and their decline with age is a major driver of chronic pain worldwide.
Robby D. Bowles, associate professor of biomedical engineering, said the paper offers direct evidence for a new insight — that DNA damage is a driver of back pain — and that BLST can be regulated therapeutically with CRISPR.

In Plain English: The Clinical Takeaway
- Scientists identified a protein, BLST, that appears to keep spinal disc cells healthy as they age. Discs with low BLST levels were older and more damaged.
- In lab-grown human disc cells, switching BLST back on reduced DNA damage and cellular aging. In rodents, switching it off sped up disc degeneration and pain behaviors.
- No BLST-based treatment exists for patients yet. This is early laboratory science, and years of safety and effectiveness testing in people would come first.
How BLST Works Inside the Disc
The mechanism of action — the biological route by which a treatment produces its effect — centers on DNA damage. Cells in spinal discs accumulate genetic damage over time, and that damage pushes them into senescence, a state in which cells stop working normally.
The study, titled “ZNF865 (BLST) a Novel Regulator of DNA Damage and Cell Senescence in Back Pain,” found BLST levels were lower in older and damaged discs, linking the protein’s decline to tissue breakdown.
CRISPR — short for clustered regularly interspaced short palindromic repeats — is a gene-editing tool that lets researchers precisely switch genes on, off, or up. In this work it served two purposes: as a laboratory instrument to prove what BLST does, and as a candidate therapeutic approach the team says could eventually be regulated in patients.
| Model Used | BLST Intervention | Observed Result |
|---|---|---|
| Human disc cells (in vitro) | BLST restored via CRISPR | Reduced signs of cellular aging and DNA damage |
| Mouse and rat models | BLST activity reduced | Disc degeneration and pain-related behaviors |
| Human disc tissue | Naturally occurring levels measured | Lower BLST in older and damaged discs |
Who Did the Work, and Who Paid for It
The research was a collaboration spanning the University of Utah’s John and Marcia Price College of Engineering, its Spencer Fox Eccles School of Medicine’s orthopaedics and arthritis specialists, and the Huntsman Cancer Institute. Coauthors also came from the University of Pennsylvania, the Icahn School of Medicine at Mount Sinai, and the University of North Carolina at Chapel Hill.
Funding came from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. That public funding matters for transparency: the finding has no commercial sponsor behind it at this stage, and the path from a rodent result to an approved therapy runs through additional preclinical studies and, eventually, clinical trials — the controlled human studies regulators require before any gene-targeted treatment reaches patients.
Beyond Back Pain: The Cancer Question
The discovery’s reach may extend past the spine. Gertz, who shares leadership of the Genomics, Epigenetics, and Metabolism Program at Huntsman Cancer Institute, said BLST is widely expressed across tissues and could be a promising target for cancer treatment and prevention, because raising BLST activity should strengthen the repair of DNA damage and the overall health of aging cells.
Bowles said the mechanisms could also apply to cancer, neurodegeneration, and any disease in which DNA damage is involved.
Both researchers flagged the same open question: whether the same mechanisms operate in age-related cancers remains unproven and requires further research.
Contraindications & When to Consult a Doctor
Any clinic or product claiming to edit the BLST gene or otherwise rejuvenate spinal discs today is not supported by this research.
Where the Science Goes Next
The team’s own framing is deliberately cautious. According to the researchers, additional preclinical work followed by clinical trials will be required to establish whether CRISPR-based targeting of BLST could be safe and effective in people. Gene-editing therapies have reached patients in other fields — including approved treatments for sickle cell disease — but spinal discs present distinct delivery and safety hurdles that no published result in this study resolves.
For Bowles, the work carries personal weight as well as scientific promise. “It has been the highlight of my career to work on a protein that was unknown and be the first to identify its function,” he said.
References
- Lewis, C., et al. “ZNF865 (BLST) a Novel Regulator of DNA Damage and Cell Senescence in Back Pain.” Aging Cell, published online October 9. onlinelibrary.wiley.com
- News-Medical: Newly characterized protein may protect spinal discs from age-related damage
- Mirage News, republishing the University of Utah College of Engineering public release: Little-Known Protein May Protect Spinal Discs From Aging
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (funding agency, per the study announcement)
Readers should consult a qualified healthcare professional about back pain or any treatment decisions.